$INFU
InfuSystem Holdings, Inc

2014 Q4 Form 10-Q Financial Statement

#000119312514404525 Filed on November 10, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2014 Q2
Revenue $16.26M $16.61M $16.37M
YoY Change -5.36% 5.55% 11.66%
Cost Of Revenue $4.040M $3.221M $2.913M
YoY Change -8.18% 17.13% 2.39%
Gross Profit $12.22M $11.73M $11.92M
YoY Change -4.38% 3.44% 15.42%
Gross Profit Margin 75.15% 70.61% 72.83%
Selling, General & Admin $8.110M $7.399M $7.522M
YoY Change -3.22% 6.09% 0.43%
% of Gross Profit 66.37% 63.08% 63.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $740.0K $100.0K $100.0K
YoY Change -90.8% 0.0% 0.0%
% of Gross Profit 6.06% 0.85% 0.84%
Operating Expenses $8.860M $9.287M $9.585M
YoY Change -2.96% -1.38% 1.23%
Operating Profit $3.360M $2.443M $2.338M
YoY Change -7.95% 27.04% 171.54%
Interest Expense -$780.0K $752.0K $776.0K
YoY Change -9.3% -10.26% -16.02%
% of Operating Profit -23.21% 30.78% 33.19%
Other Income/Expense, Net -$10.00K -$749.0K -$736.0K
YoY Change -66.67% -11.36% -18.22%
Pretax Income $1.980M $1.694M $1.602M
YoY Change 26.11% 57.14% -4207.69%
Income Tax $950.0K $842.0K $716.0K
% Of Pretax Income 47.98% 49.7% 44.69%
Net Earnings $1.040M $852.0K $886.0K
YoY Change 20.93% 31.28% 743.81%
Net Earnings / Revenue 6.4% 5.13% 5.41%
Basic Earnings Per Share $0.04 $0.04
Diluted Earnings Per Share $45.00K $0.04 $0.04
COMMON SHARES
Basic Shares Outstanding 22.28M shares 22.20M shares 22.15M shares
Diluted Shares Outstanding 22.51M shares 22.40M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $500.0K $1.900M $1.000M
YoY Change -54.55% 111.11% 900.0%
Cash & Equivalents $515.0K $1.902M $1.041M
Short-Term Investments
Other Short-Term Assets $633.0K $621.0K $712.0K
YoY Change 22.2% -0.64% -0.14%
Inventory $1.758M $1.589M $1.485M
Prepaid Expenses
Receivables $10.30M $11.51M $10.77M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $15.46M $17.91M $16.30M
YoY Change -2.68% 26.57% 19.69%
LONG-TERM ASSETS
Property, Plant & Equipment $2.451M $2.370M $1.577M
YoY Change 181.08% 191.51% 97.62%
Goodwill
YoY Change
Intangibles $25.07M $24.46M $24.29M
YoY Change 3.68% 1.6% 0.27%
Long-Term Investments
YoY Change
Other Assets $212.0K $208.0K $248.0K
YoY Change -2.3% 13.04% 57.96%
Total Long-Term Assets $64.76M $63.11M $61.43M
YoY Change 5.31% 1.4% -1.12%
TOTAL ASSETS
Total Short-Term Assets $15.46M $17.91M $16.30M
Total Long-Term Assets $64.76M $63.11M $61.43M
Total Assets $80.21M $81.02M $77.74M
YoY Change 3.67% 6.06% 2.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.215M $4.570M $4.101M
YoY Change 10.11% 5.57% 6.99%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $6.452M $4.238M $3.871M
YoY Change 26.06% 30.84% 23.91%
Total Short-Term Liabilities $14.73M $12.11M $10.55M
YoY Change 12.94% 16.54% 8.28%
LONG-TERM LIABILITIES
Long-Term Debt $19.03M $23.63M $22.83M
YoY Change -11.93% -3.07% -9.42%
Other Long-Term Liabilities $3.000M
YoY Change
Total Long-Term Liabilities $19.03M $23.63M $22.83M
YoY Change -11.93% -3.07% -9.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.73M $12.11M $10.55M
Total Long-Term Liabilities $19.03M $23.63M $22.83M
Total Liabilities $33.76M $35.74M $33.37M
YoY Change -2.57% 2.79% -4.49%
SHAREHOLDERS EQUITY
Retained Earnings -$43.71M -$44.74M -$45.59M
YoY Change -7.13% -6.65% -6.14%
Common Stock $2.000K $2.000K $2.000K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $46.45M $45.28M $44.36M
YoY Change
Total Liabilities & Shareholders Equity $80.21M $81.02M $77.74M
YoY Change 3.67% 6.06% 2.62%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2014 Q2
OPERATING ACTIVITIES
Net Income $1.040M $852.0K $886.0K
YoY Change 20.93% 31.28% 743.81%
Depreciation, Depletion And Amortization $740.0K $100.0K $100.0K
YoY Change -90.8% 0.0% 0.0%
Cash From Operating Activities $3.060M $2.390M $2.450M
YoY Change 13.75% -5.91% 308.33%
INVESTING ACTIVITIES
Capital Expenditures -$2.540M -$2.650M $500.0K
YoY Change -0.78% 215.48% -164.1%
Acquisitions
YoY Change
Other Investing Activities $1.680M $1.180M $2.760M
YoY Change 69.7% 9.26% 331.25%
Cash From Investing Activities -$860.0K -$1.460M -$650.0K
YoY Change -45.22% -684.0% 306.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.570M -90.00K -1.250M
YoY Change 301.12% -95.45% 52.44%
NET CHANGE
Cash From Operating Activities 3.060M 2.390M 2.450M
Cash From Investing Activities -860.0K -1.460M -650.0K
Cash From Financing Activities -3.570M -90.00K -1.250M
Net Change In Cash -1.370M 840.0K 550.0K
YoY Change -695.65% 3.7% -244.74%
FREE CASH FLOW
Cash From Operating Activities $3.060M $2.390M $2.450M
Capital Expenditures -$2.540M -$2.650M $500.0K
Free Cash Flow $5.600M $5.040M $1.950M
YoY Change 6.67% 49.11% 41.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22284589 shares
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
908000
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22400743 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22203053 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0775 pure
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3303000
CY2014Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2014Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
22116000
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
12111000
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4570000
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44740000
CY2014Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
4238000
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
45282000
CY2014Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
454000
CY2014Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
23631000
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
81024000
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
90020000
CY2014Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1053000
CY2014Q3 us-gaap Liabilities
Liabilities
35742000
CY2014Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
4246000
CY2014Q3 us-gaap Long Term Debt
LongTermDebt
27869000
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5287000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1902000
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2583000
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2370000
CY2014Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
40778000
CY2014Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
14696000
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2191000
CY2014Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1349000
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
11361000
CY2014Q3 us-gaap Assets
Assets
81024000
CY2014Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2296000
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2832000
CY2014Q3 us-gaap Inventory Net
InventoryNet
1589000
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11505000
CY2014Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24461000
CY2014Q3 us-gaap Other Assets Current
OtherAssetsCurrent
621000
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
208000
CY2014Q3 us-gaap Assets Current
AssetsCurrent
17913000
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
749000
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2745000
CY2014Q3 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
2365000
CY2014Q3 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
40930000
CY2014Q3 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
23153000
CY2014Q3 infu Medical Equipment Net
MedicalEquipmentNet
20027000
CY2014Q3 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
115000
CY2014Q3 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
16317000
CY2014Q3 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
17662000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2326000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22158041 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21960351 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3187000
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13041000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4736000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47062000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
217000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.287 pure
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
192200 shares
CY2013Q4 us-gaap Assets Current
AssetsCurrent
15883000
CY2013Q4 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
3664000
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
518000
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5118000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
42723000
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
21609000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77373000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89783000
CY2013Q4 us-gaap Liabilities
Liabilities
34650000
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
26727000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4774000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1138000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
872000
CY2013Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
38620000
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
16300000
CY2013Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1817000
CY2013Q4 us-gaap Assets
Assets
77373000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2296000
CY2013Q4 us-gaap Inventory Net
InventoryNet
1234000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10697000
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24182000
CY2013Q4 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
37252000
CY2013Q4 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
22727000
CY2013Q4 infu Medical Equipment Net
MedicalEquipmentNet
18102000
CY2013Q4 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
87000
CY2013Q4 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
14438000
CY2013Q4 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
14438000
CY2014Q2 infu Debt Instrument Effective Floating And Fixed Interest Rate Increase Decrease
DebtInstrumentEffectiveFloatingAndFixedInterestRateIncreaseDecrease
-0.0150 pure
CY2014Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1600000
CY2014Q3 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.080 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
4765000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22043998 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21851798 shares
us-gaap Gross Profit
GrossProfit
32093000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3547000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
27912000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3396000
us-gaap Sales Revenue Net
SalesRevenueNet
45103000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
2808000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14622000
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
22395000
infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
3800000
infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
4836000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1129000
us-gaap Operating Income Loss
OperatingIncomeLoss
3436000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
805000
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
41556000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2307000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
78000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
329000
us-gaap Net Income Loss
NetIncomeLoss
805000
us-gaap Interest Expense
InterestExpense
2636000
us-gaap Operating Expenses
OperatingExpenses
28657000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7281000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8174000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4782000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1972000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1418000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
324000
us-gaap Depreciation
Depreciation
200000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-5595000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-588000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
InfuSystem Holdings, Inc
dei Trading Symbol
TradingSymbol
INFU
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.451 pure
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
256856 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
4204000
us-gaap Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
LIBOR plus 6.75% (with a LIBOR floor of 1.0%, for an effective fixed rate of 7.75%) or the Wells Fargo prime rate plus 4.75% (with a prime rate floor of 3.0%, for an effective floating rate of 8.0%).
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2016-11-30
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22364999 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
dei Entity Central Index Key
EntityCentralIndexKey
0001337013
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22108143 shares
us-gaap Gross Profit
GrossProfit
35729000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
6077000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
49101000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
7168000
us-gaap Sales Revenue Net
SalesRevenueNet
50227000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4228000
us-gaap Operating Income Loss
OperatingIncomeLoss
6557000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2321000
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
44150000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2329000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
178000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26000
us-gaap Net Income Loss
NetIncomeLoss
2321000
us-gaap Interest Expense
InterestExpense
2355000
us-gaap Operating Expenses
OperatingExpenses
29172000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7762000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9024000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4811000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1876000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
764000
CY2014Q3 infu Effect Of Change In Accounting Estimate On Estimated Useful Life Of Assets Increase Decrease Net Income
EffectOfChangeInAccountingEstimateOnEstimatedUsefulLifeOfAssetsIncreaseDecreaseNetIncome
200000
infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
5474000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1907000
us-gaap Depreciation
Depreciation
200000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1465000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1975000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
5193000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14723000
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
47814000
infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
2400000
infu Effect Of Change In Accounting Estimate On Estimated Useful Life Of Assets
EffectOfChangeInAccountingEstimateOnEstimatedUsefulLifeOfAssets
1400000
infu Effect Of Change In Accounting Estimate On Estimated Useful Life Of Assets Earnings Per Share Basic And Diluted
EffectOfChangeInAccountingEstimateOnEstimatedUsefulLifeOfAssetsEarningsPerShareBasicAndDiluted
0
infu Effect Of Change In Accounting Estimate On Estimated Useful Life Of Assets Increase Decrease Net Income
EffectOfChangeInAccountingEstimateOnEstimatedUsefulLifeOfAssetsIncreaseDecreaseNetIncome
800000
CY2014Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
500000
CY2013 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2014Q1 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P7Y
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2013Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.398 pure
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
184491 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22075532 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21891041 shares
CY2013Q3 us-gaap Gross Profit
GrossProfit
11340000
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1247000
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
15740000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1078000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1923000
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22203053 shares
CY2014Q3 us-gaap Gross Profit
GrossProfit
11730000
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2108000
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
16613000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1694000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2443000
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
852000
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
308106 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22511159 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2014Q3 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
14505000
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-749000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
649000
CY2013Q3 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
14493000
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-845000
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
649000
CY2013Q3 us-gaap Interest Expense
InterestExpense
838000
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
9417000
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2391000
CY2013Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2750000
CY2013Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1795000
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
648000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
429000
CY2013Q3 us-gaap Depreciation
Depreciation
100000
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4583000
CY2013Q3 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
1300000
CY2013Q3 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
1650000
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2014Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.498 pure
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
852000
CY2014Q3 us-gaap Interest Expense
InterestExpense
752000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
9287000
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2483000
CY2014Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3221000
CY2014Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1266000
CY2014Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
622000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
842000
CY2014Q3 us-gaap Depreciation
Depreciation
100000
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4916000
CY2014Q3 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
900000
CY2014Q3 infu Effect Of Change In Accounting Estimate On Estimated Useful Life Of Assets
EffectOfChangeInAccountingEstimateOnEstimatedUsefulLifeOfAssets
400000
CY2014Q3 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
1662000

Files In Submission

Name View Source Status
0001193125-14-404525-index-headers.html Edgar Link pending
0001193125-14-404525-index.html Edgar Link pending
0001193125-14-404525.txt Edgar Link pending
0001193125-14-404525-xbrl.zip Edgar Link pending
d810092d10q.htm Edgar Link pending
d810092dex101.htm Edgar Link pending
d810092dex311.htm Edgar Link pending
d810092dex312.htm Edgar Link pending
d810092dex321.htm Edgar Link pending
d810092dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g810092g64i32.jpg Edgar Link pending
infu-20140930.xml Edgar Link completed
infu-20140930.xsd Edgar Link pending
infu-20140930_cal.xml Edgar Link unprocessable
infu-20140930_def.xml Edgar Link unprocessable
infu-20140930_lab.xml Edgar Link unprocessable
infu-20140930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending